Followers | 6685 |
Posts | 22551 |
Boards Moderated | 2 |
Alias Born | 06/27/2006 |
![](https://investorshub.advfn.com/uicon/75364.png?cb=1465133456)
Monday, September 07, 2020 12:18:56 PM
It does not matter to me whether or not someone agrees with my posts or the optimism I have for the future of BRTXQ and its' equity going forward. I do however, implore you the reader, to gauge the veracity of information that has been posted, in comparison to price volatility, versus against what is publicly available information, in this case Pacer. Then, take the recent history and counterbalance all of that and focus on what occurred in the last 45 minutes of trading in BRTXQ on Friday. In relation to that, how fast the price rose relative to volume. Whether you are for the stock or against it, I again, implore all readers of this post to exercise judicious common sense, practicality and relative pragmatism. I have said it a 1,000 times and I will reiterate it in this post again. NO ONE SHOULD BASE ANY IMPORTANT FINANCIAL DECISIONS PREDICATED ON SOCIAL MEDIA. DON'T TRUST ANYBODY ON THESE FORUMS, THAT GOES FOR ME INCLUDED. I standby my information and rely on great calls to earn trust and weight on my opinions, buy again, they are just OPINIONS. PLEASE READ the voluminous amount of information that has been posted here over the past few weeks. YOU MUST TAKE RESPONSIBILITY FOR IMPORTANT FINANCIAL DECISIONS. DON'T BE LAZY. DO THE WORK!!Your respective and collective trust and confidence should be earned, consistently. Recidivistic success should be the lynchpin by which one measures trust and confidence with individual posters based upon past history.
In the context of the aforementioned here is my thoughts on the upcoming week:
TUESDAY--Sometime tomorrow the results of the shareholder ballots will be revealed via PACER and/or Twitter. As I stated over three weeks ago, the results adopting AUCTUS' plan will BE APPROVED, as they control over 51% of the equity. If the aforementioned statement doesn't do it for you, keep in mind that AUCTUS' plan is the ONLY current plan that preserves the commons. How many shareholders would vote NO? You would have to be a masochist to vote for anything other than YES. Illusions contemplating any other outcome are not based on logic. Once announced, officially, the stock price will escalate quickly and exponentially upwards. If one was intellectually adept, one might want to anticipate this result and take it as a given and get ahead of the herd so to speak.
WEDNESDAY--The cacophony of banter back and forth will be epic. Once again, analyze your respective INFORMED, (operative word right there), opinion and understand what is happening and why it is happening. Discard the noise, on both sides, decide whether or not you want to hold into the hearing on Thursday. For my part, I am 100% holding through. I have done my DD. I do not care about the nonsense. But that is me, I am not you. I do not know your financial position, your risk tolerance or what your investor goals are. ONLY YOU, can make that decision.
THURSDAY--The hearing is scheduled in Judge Grossman's courtroom in the Eastern District of New York at 11:30 am. The results of this hearing will likely hit Pacer that night or Friday. Again, I am not the least bit concerned about the final outcome. It is the ONLY logical conclusion to all of the events leading up to this event.
I sincerely wish everyone here the utmost success and good wishes for whatever you ultimately decide. Take solace in the actions you are taking towards the ultimate goal of financial freedom for you and your respective loved ones, BY DOING YOUR DD.
BEST REGARDS,
SPORTYNORTY
Recent BRTX News
- BioRestorative Therapies’ Chief Scientist Named New Section Editor of the Prestigious Journal of Translational Medicine • GlobeNewswire Inc. • 07/23/2024 11:10:00 AM
- BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program • GlobeNewswire Inc. • 06/27/2024 11:40:00 AM
- BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 06/17/2024 11:05:00 AM
- Shares of Biotech MicroCap Rip on Licensing Talks • AllPennyStocks.com • 06/13/2024 03:40:00 PM
- BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem® Metabolic Disease Program • GlobeNewswire Inc. • 06/13/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/11/2024 08:28:30 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 06/11/2024 08:23:50 PM
- BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference • GlobeNewswire Inc. • 06/04/2024 12:50:00 PM
- BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice • GlobeNewswire Inc. • 05/24/2024 11:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:51:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:45:27 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/16/2024 09:17:17 PM
- BioRestorative Therapies Provides First Quarter 2024 Business Update • GlobeNewswire Inc. • 05/14/2024 08:10:00 PM
- BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity • GlobeNewswire Inc. • 05/08/2024 11:30:00 AM
- BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 • GlobeNewswire Inc. • 04/30/2024 08:15:00 PM
- BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology • GlobeNewswire Inc. • 04/30/2024 11:30:00 AM
- Biotech Catches Major Premarket Bid Following FDA Clearance • AllPennyStocks.com • 04/16/2024 02:25:00 PM
- BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment • GlobeNewswire Inc. • 04/16/2024 11:45:00 AM
- BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease • GlobeNewswire Inc. • 04/08/2024 11:45:00 AM
- BioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued Warrants • GlobeNewswire Inc. • 04/03/2024 08:38:00 PM
- BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K • GlobeNewswire Inc. • 04/01/2024 11:45:00 AM
- BioRestorative Therapies to Participate in the 36th Annual ROTH Conference • GlobeNewswire Inc. • 03/11/2024 08:15:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/06/2024 09:34:22 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/15/2024 09:43:54 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/15/2024 09:40:53 PM
FEATURED Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • Jul 29, 2024 9:07 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM